Form 4: CareDx Officer Acquires Shares in Tax Withholding
Statement of Changes in Beneficial Ownership
CareDx, Inc. officer Jeffrey Adam Novack acquired 1,892 shares of common stock through a tax withholding transaction on April 6, 2026.
Summary
- Jeffrey Adam Novack, Secretary and General Counsel of CareDx, Inc., acquired 1,892 shares of common stock.
- The acquisition occurred on April 6, 2026, with a transaction price of $17.82 per share.
- These shares were withheld by the Issuer to cover tax obligations related to the vesting of restricted stock units.
- Following this transaction, Novack beneficially owns 119,485 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, as it represents a routine tax-related share withholding rather than a new investment or divestment decision by management.
Positives
- Officer's continued direct ownership of a significant number of shares (119,485) indicates alignment with shareholder interests.
- The transaction is a standard procedure for managing tax liabilities on equity awards, suggesting normal operational processes.
Negatives
- The acquisition was not an open market purchase, but rather a withholding of shares for tax purposes, which does not represent new investment by the officer.
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing, as it solely reports a past transaction.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions in the biotechnology and healthcare sectors, providing transparency on executive shareholdings and activities.
Stakeholder Impact
- Shareholders: The filing provides transparency on insider shareholdings, reinforcing governance standards. The transaction itself does not directly impact share count or company finances.
Key Dates
| Date | Description |
|---|---|
| 04/06/2026 | Transaction Date for acquisition of common stock. |
| 04/07/2026 | Date of signature for the filing. |
Keywords
Form 4, SEC Filing, Insider Transaction, CareDx, CDNA, Stock Acquisition, Tax Withholding, Restricted Stock Units, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.